The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years … – Nature.com

World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol. Rec. 89(25), 265288 (2014).

Google Scholar

Gershon, A. A. et al. Varicella zoster virus infection. Nat. Rev. Dis. Primers. 1(1), 18 (2015).

Article Google Scholar

Varela, F. H., Pinto, L. A. & Scotta, M. C. Global impact of varicella vaccination programs. Hum. Vaccin. Immunother. 15(3), 645657 (2019).

Article PubMed Google Scholar

Prymula, R. et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet 1, 13131324 (2014).

Article Google Scholar

Kuter, B. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr. Infect. Dis. J. 23(2), 132137 (2004).

Article PubMed Google Scholar

Baxter, R. et al. Long-term effectiveness of varicella vaccine: A 14-year, prospective cohort study. Pediatrics 131(5), 13891396 (2013).

Article Google Scholar

Marin, M., Marti, M., Kambhampati, A., Jeram, S. M. & Seward, J. F. Global varicella vaccine effectiveness: A meta-analysis. Pediatrics 137(3), 1 (2016).

Article Google Scholar

Merck & Co., Inc., Rahway, NJ, USA. PROQUAD(R) (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) [Prescribing Information]. 02 2023. [Online]. Available: https://www.merck.com/product/usa/pi_circulars/p/proquad/proquad_pi_4171.pdf. [Accessed 26 05 2023].

GlaxoSmithKline Inc. PRIORIX-TETRA (Combined measles, mumps, rubella and varicella vaccine, live, attenuated) [Product Monograph]. 08 2019. [Online]. Available: https://ca.gsk.com/media/6253/priorix-tetra.pdf. [Accessed 26 05 2023].

DAncona, F., DAmario, C., Maraglino, F., Rezza, G. & Iannazzo, S. The law on compulsory vaccination in Italy: An update 2 years after the introduction. Eurosurveillance 24(26), 1900371 (2019).

Article PubMed PubMed Central Google Scholar

Spoulou, V. et al. Implementing universal varicella vaccination in Europe: The path forward. Pediatr. Infect. Dis. J. 38(2), 181188 (2019).

Article PubMed Google Scholar

Trucchi, C., Gabutti, G., Rota, M. C. & Bella, A. Burden of varicella in Italy, 20012010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J. Med. Microbiol. 64(11), 13871394 (2015).

Article PubMed Google Scholar

Amodio, E. et al. Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy 20032018). Vaccine 38, 56015606 (2020).

Article PubMed Google Scholar

Azzari, C. et al. The cost-effectiveness of universal varicella vaccination in Italy: A model-based assessment of vaccination strategies. Clinicoecon. Outcomes Res. 12, 273 (2020).

Article CAS PubMed PubMed Central Google Scholar

Wutzler, P. et al. Varicella vaccinationthe global experience. Expert. Rev. Vaccines 16(8), 883843 (2017).

Article Google Scholar

Marin, M. et al. Decline in severe varicella disease during the United States varicella vaccination program: hospitalizations and deaths, 19902019. J. Infect. Dis. 226(Suppl 4), S407S415 (2022).

Article PubMed Google Scholar

Direzione generale della prevenzione sanitaria, "Vaccinazioni dell'et pediatrica e dell'adolescenza - Coperture vaccinali," 19 10 2022. [Online]. Available: https://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=20. [Accessed 26 05 2023].

European Centre for Disease Prevention and Control (ECDC). Vaccine Scheduler, Italy: recommended vaccinations. 04 11 2021. [Online]. Available: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByCountry?SelectedCountryId=103&IncludeChildAgeGroup=true&IncludeChildAgeGroup=false&IncludeAdultAgeGroup=true&IncludeAdultAgeGroup=falseLast. [Accessed 26 05 2023].

Agenzia Italiana del Farmaco. Linea guida per la compilazione del Dossier a supporto della domanda di rimborsabilit e prezzo di un medicinaleEstratto sezione E. Agenzia Italiana del Farmaco, Roma (2020).

United Nations Childrens Fund. The State of the World's Children 2023: For every child, vaccination. UNICEF InnocentiGlobal Office of Research and Foresight, Florence (2023).

Bozzola, E. et al. Pediatric hospitalization for varicella in an Italian pediatric hospital: How much does it cost?. Int. J. Environ. Res. Public Health 18(22), 12053 (2021).

Article CAS PubMed PubMed Central Google Scholar

Jang, S. et al. Factors shaping the COVID-19 epidemic curve: A multi-country analysis. BMC Infect. Dis. 21, 1032 (2021).

Article CAS PubMed PubMed Central Google Scholar

Buonomo, B. & Marca, R. Effects of information-induced behavioural changes during the COVID-19 lockdowns: The case of Italy. R. Soc. Open Sci. 7, 201635 (2020).

Article ADS CAS PubMed PubMed Central Google Scholar

World Health Organization. Immunization coverage. 14 07 2022. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. [Accessed 19 05 2023].

World Health Organization. Global partners annouce a new effort"The Big Catch-up"to vaccinate millions of children and restore immunization progress lost during the pandemic 24 04 2023. [Online]. Available: https://www.who.int/news/item/24-04-2023-global-partners-announce-a-new-effort-the-big-catch-up-to-vaccinate-millions-of-children-and-restore-immunization-progress-lost-during-the-pandemic. [Accessed 19 05 2023].

Wolfson, L. J. et al. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PLoS One 14(8), 1 (2019).

Article Google Scholar

Heininger, U. et al. Health impact and cost-effectiveness assessment for the introduction of universal varicella vaccination in Switzerland. Pediatr. Infect. Dis. J. 40(6), 217221 (2021).

Article Google Scholar

Pawaskar, M., Burgess, C., Pillsbury, M., Wislff, T. & Flem, E. Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLoS ONE 16(7), 1 (2021).

Article Google Scholar

Burgess, C., Kujawski, S., Lapornik, A., Bencina, G. & Pawaskar, M. The long-term clinical and economic impact of universal varicella vaccination in Slovenia. J. Health Econ. Outcomes Res. 9(2), 95102 (2022).

Article PubMed PubMed Central Google Scholar

Sharomi, O. et al. Modeling the impact of exogenous boosting and universal varicella vaccination on the clinical and economic burden of varicella and herpes zoster in a dynamic population for England and Wales. Vaccines 10(9), 1416 (2022).

Article PubMed PubMed Central Google Scholar

Kujawski, S. A. et al. "The health and economic impact of switching vaccines in universal varicella vaccination programs using a dynamic transmission model: An Israel case study. Hum. Vaccines Immunother. 212, 4784 (2022).

Google Scholar

Maman, K. et al. The value of childhood combination vaccines: From beliefs to evidence. Hum. Vaccines Immunother. 11(9), 21322141 (2015).

Article Google Scholar

Talbird, S. E. et al. Understanding the role of exogenous boosting in modeling varicella vaccination. Expert Rev. Vaccines 17(11), 10211035 (2018).

Article CAS PubMed Google Scholar

Burgess, C., Samant, S., Fevre, T., Schade Larsen, C. & Pawaskar, M. Universal varicella vaccination in Denmark: Modeling public health impact, age-shift, and cost-effectiveness. PLOS Global Public Health 3(4), e0001743 (2023).

Article PubMed PubMed Central Google Scholar

Pillsbury, M., Carias, C., Samant, S., Greenberg, D. & Pawaskar, M. Comparison of performance of varicella vaccines via infectious disease modeling. Vaccine 40(29), 39543962 (2022).

Article CAS PubMed Google Scholar

Scalone, L., Cortesi, P. A., Ciampichini, R., Cesana, G. & Mantovani, L. G. Health Related Quality of Life norm data of the general population in Italy: Results using the EQ-5D-3L and EQ-5D-5L instruments. Epidemiol. Biostat. Public Health 12(3), e11457 (2015).

Google Scholar

De Donno, A. et al. Has VZV epidemiology changed in Italy? Results of a seroprevalence study. Hum. Vaccines Immunother. 13(2), 385390 (2017).

Article Google Scholar

G. Gabutti, M. C. Rota, M. Guido, A. De Donno, A. Bella, M. L. Ciofi (2008) The epidemiology of varicella zoster virus infection in Italy. BMC Public Health 8:372.

Gialloreti, L. E. et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study. BMC Infect. Dis. 10(1), 230 (2010).

Article PubMed PubMed Central Google Scholar

Alicino, C. et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study. Hum. Vaccines Immunother. 13(2), 399404 (2017).

Article Google Scholar

Instituto Nazionale di Statistica,, "I.Stat," 2023. [Online]. Available: http://dati.istat.it/Index.aspx. [Accessed 26 05 2023].

Eurostat, "Real GDP per capita," 25 05 2023. [Online]. Available: https://ec.europa.eu/eurostat/databrowser/view/sdg_08_10/default/table?lang=en. [Accessed 26 05 2023].

Barbieri, E. et al. The economic burden of pneumococcal disease in children: A population-based investigation in the Veneto region of Italy. Children 9(9), 1347 (2022).

Article PubMed PubMed Central Google Scholar

Ministero della Salute. DPCM 12 gennaio 2017, Allegato 4 (Ministero della Salute, 2017).

Google Scholar

Coudeville, L., Paree, F., Lebrun, T. & Sailly, J. C. The value of varicella vaccination in healthy children: Cost-benefit analysis of the situation in France. Vaccine 17(2), 142151 (1999).

Article CAS PubMed Google Scholar

Coudeville, L., Brunot, A., Giaquinto, C., Lucioni, C. & Dervaux, B. Varicella vaccination in Italy: An economic evaluation of different scenarios. Pharmacoeconomics 22(13), 839855 (2004).

Article PubMed Google Scholar

Fornaro, P. et al. Epidemiology and cost analysis of varicella in Italy: Results of a sentinel study in the pediatric practice. Pediatr. Infect. Dis. J. 18(5), 414419 (1999).

Article CAS PubMed Google Scholar

Giaquinto, C. et al. Epidemiology and outcomes of varicella in Italy: results of a prospective study of children (014 years old) followed up by pediatricians (Pedianet study). Annali di Igiene: Medicina Preventiva e di Comunita 14(4 Suppl 6), 2127 (2002).

CAS PubMed Google Scholar

Ministero dell'Economia e delle Finanze, "Libro verde sulla spesa pubblica. Spendere meglio: alcune prime indicazioni," 2007. [Online]. Available: https://www.mef.gov.it/ministero/commissioni/ctfp/documenti/Libro_verde_spesa_pubblica.pdf. [Accessed 26 05 2023].

Farmadati Italia,, "Farmadati Italia," 2022. [Online]. Available: https://www.farmadati.it/. [Accessed 26 10 2022].

Schink, T., Holstiege, J., Kowalzik, F., Zepp, F. & Garbe, E. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+ V vaccination. Vaccine 32(6), 645650 (2014).

Article CAS PubMed Google Scholar

Ministero Della Salute. Gazzetta Ufficiale, Serie Generale n. 23 del 2812013: Supplemento Ordinario n. 8. 2013. 128 2013. 28 01 2013. [Online]. Available: https://www.gazzettaufficiale.it/eli/gu/2013/01/28/23/so/8/sg/pdf. [Accessed 26 05 2023].

Riera-Montes, M. et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect. Dis. 17(1), 353 (2017).

Article PubMed PubMed Central Google Scholar

Baldo, V. et al. Varicella: Epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect. Dis. 9(1), 150 (2009).

Article PubMed PubMed Central Google Scholar

Originally posted here:

The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years ... - Nature.com